TABLE OF CONTENTS
| | | | Volume 36, Issue 25 (June 2017) | | In this issue Original Articles Short Communication Letter to the Editor Retraction
Also new AOP | | | | | Advertisement | | | | | Original Articles | Top | | Cell-to-cell heterogeneity of EWSR1-FLI1 activity determines proliferation/migration choices in Ewing sarcoma cells OPENG-A Franzetti, K Laud-Duval, W van der Ent, A Brisac, M Irondelle, S Aubert, U Dirksen, C Bouvier, G de Pinieux, E Snaar-Jagalska, P Chavrier and O Delattre Oncogene 2017 36: 3505-3514; advance online publication, January 30, 2017; 10.1038/onc.2016.498 Abstract | Full Text | | | | Mutant p53 oncogenic functions in cancer stem cells are regulated by WIP through YAP/TAZM Escoll, R Gargini, A Cuadrado, I M Anton and F Wandosell Oncogene 2017 36: 3515-3527; advance online publication, February 6, 2017; 10.1038/onc.2016.518 Abstract | Full Text | | | | LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cellsH Xiong, Z Ni, J He, S Jiang, X Li, J He, W Gong, L Zheng, S Chen, B Li, N Zhang, X Lyu, G Huang, B Chen, Y Zhang and F He Oncogene 2017 36: 3528-3540; advance online publication, February 6, 2017; 10.1038/onc.2016.521 Abstract | Full Text | | | | RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinomaY Liu-Chittenden, M Jain, K Gaskins, S Wang, M J Merino, S Kotian, S Kumar Gara, S Davis, L Zhang and E Kebebew Oncogene 2017 36: 3541-3552; advance online publication, January 23, 2017; 10.1038/onc.2016.497 Abstract | Full Text | | | | Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysisJ-R Jhan and E R Andrechek Oncogene 2017 36: 3553-3561; advance online publication, January 30, 2017; 10.1038/onc.2016.503 Abstract | Full Text | | | | KLF6 depletion promotes NF-κB signaling in glioblastoma OPENA P Masilamani, R Ferrarese, E Kling, N K Thudi, H Kim, D M Scholtens, F Dai, M Hadler, T Unterkircher, L Platania, A Weyerbrock, M Prinz, G Y Gillespie, G R Harsh IV, M Bredel and M S Carro Oncogene 2017 36: 3562-3575; advance online publication, February 6, 2017; 10.1038/onc.2016.507 Abstract | Full Text | | | | A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR OPENT-S Lau, L K-Y Chan, E C-H Wong, C W-C Hui, K Sneddon, T-H Cheung, S-F Yim, J H-S Lee, C S-Y Yeung, T K-H Chung and J Kwong Oncogene 2017 36: 3576-3587; advance online publication, February 6, 2017; 10.1038/onc.2016.509 Abstract | Full Text | | | | Upregulation of MARCKS in kidney cancer and its potential as a therapeutic targetC-H Chen, L W R Fong, E Yu, R Wu, J F Trott and R H Weiss Oncogene 2017 36: 3588-3598; advance online publication, February 6, 2017; 10.1038/onc.2016.510 Abstract | Full Text | | | | Chemerin has a protective role in hepatocellular carcinoma by inhibiting the expression of IL-6 and GM-CSF and MDSC accumulationY Lin, X Yang, W Liu, B Li, W Yin, Y Shi and R He Oncogene 2017 36: 3599-3608; advance online publication, February 6, 2017; 10.1038/onc.2016.516 Abstract | Full Text | | | | Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanomaS Luo, Y Li, R Ma, J Liu, P Xu, H Zhang, K Tang, J Ma, N Liu, Y Zhang, Y Sun, T Ji, X Liang, X Yin, Y Liu, W Tong, Y Niu, N Wang, X Wang and B Huang Oncogene 2017 36: 3609-3617; advance online publication, February 6, 2017; 10.1038/onc.2016.520 Abstract | Full Text | | | | Detecting intratumoral heterogeneity of EGFR activity by liposome-based in vivo transfection of a fluorescent biosensor OPENG Weitsman, N J Mitchell, R Evans, A Cheung, T L Kalber, R Bofinger, G O Fruhwirth, M Keppler, Z V F Wright, P R Barber, P Gordon, T de Koning, W Wulaningsih, K Sander, B Vojnovic, S Ameer-Beg, M Lythgoe, J N Arnold, E Årstad, F Festy, H C Hailes, A B Tabor and T Ng Oncogene 2017 36: 3618-3628; advance online publication, February 6, 2017; 10.1038/onc.2016.522 Abstract | Full Text | | | | Oncogenic activity of amplified miniature chromosome maintenance 8 in human malignanciesD-M He, B-G Ren, S Liu, L-Z Tan, K Cieply, G Tseng, Y P Yu and J-H Luo Oncogene 2017 36: 3629-3639; advance online publication, May 8, 2017; 10.1038/onc.2017.123 Abstract | Full Text | | Short Communication | Top | | The SigmaR1 chaperone drives breast and colorectal cancer cell migration by tuning SK3-dependent Ca2+ homeostasisM Gueguinou, D Crottès, A Chantôme, R Rapetti-Mauss, M Potier-Cartereau, L Clarysse, A Girault, Y Fourbon, P Jézéquel, C Guérin-Charbonnel, G Fromont, P Martin, B Pellissier, R Schiappa, E Chamorey, O Mignen, A Uguen, F Borgese, C Vandier and O Soriani Oncogene 2017 36: 3640-3647; advance online publication, January 23, 2017; 10.1038/onc.2016.501 Abstract | Full Text | | Letter to the Editor | Top | | Pancreatic fibroblast exosomes regulate survival of cancer cellsS Suklabaidya, P Dash and S Senapati Oncogene 2017 36: 3648-3649; advance online publication, February 6, 2017; 10.1038/onc.2016.528 Full Text | | Retraction | Top | | PRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2J Shen, H Vakifahmetoglu, H Stridh, B Zhivotovsky and K G Wiman Oncogene 2017 36: 3650; advance online publication, February 13, 2017; 10.1038/onc.2017.9 Full Text | | | | | | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. | | | | |
No comments:
Post a Comment